The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
1 pt

Opinion on  ImmunoCellular Therapeutics Ltd. (IMUC)
ImmunoCellular (OTC: IMUC.OB): Griffin Maintains Buy Rating with $3.25 Target

Nov 09, 2009 08:29 PM GMT
Mikerun
Return Risk
+1.04% MID
Principal

 
Griffin Securities issued an updated research report today on ImmunoCellular Therapeutics (OTC: IMUC.OB), which includes a price objective of $3.25 per share. Below are some highlights from the report, which is available to view or download as a PDF at the <font> BioMedReports.com research downloads </font> section and at the <font> ProActive News Room landing page for IMUC </font> .
 
IMUC is an emerging cancer immunotherapy company that is developing therapeutic and diagnostic product candidates taking aim at the root cause of the disease, cancer stem cells (CSCs), based on two distinct technology platforms - active (cancer vaccines) and passive (monoclonal antibodies or mAbs).
 
1.) The Phase I trial of ICT-107 yields tantalizing efficacy data against glioblastoma and with no safety issues.
 
2.) Roche (OTC: RHHBY.PK) licenses ICT-69 antibody therapy for multiple myeloma and ovarian cancer; more deals in the making.
 
3.) Therapies advance in the R&D pipeline, and the Company is preparing for new clinical trials.
 
4.) We reiterate our BUY recommendation and maintain our target price of $3.25 per share.
 
Early next year (1Q10 which ends 3/31/10), IMUC expects to make an IND filing with the FDA for permission to begin human clinical trials for a Phase 1 study of its off-the-shelf cancer stem cell vaccine candidate (ICT-121). IND Filings for ICT?121 are expected for Brain Tumors in US or Europe during 1Q10 while IND Filings for ICT?121 for Pancreatic Cancer are expected in the US or Europe during 3Q10.
 
The <font> BioMedReports.com FDA Calendar service </font> includes a database with over 400 entries of (1) pending new drug, biological agent, or medical device new product decisions at the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, and sBLA filings); (2) pending new submissions to the FDA; (3) pending complete response letter (CRL) re-submissions to the FDA; and (4) pending clinical trial results.
 
Coming soon is a premium service offered in collaboration with Investars YOU for full access to a global database of over 1,000 stocks which are organized and managed within my <font> 22 ProActive HavRx stock indexes </font> . This service will allow investors to create custom portfolios, personalized exchange-traded funds (ETFs), and generate investment ideas based on their personal preferences, beliefs, and opinions through specialized stock indexes that are organized and targeted toward a wide variety of themes.
 
Disclosure: Long IMUC.OB


IMUC:  This call was made on 11/09/09 @ $0.0
Rating:   Positive   $0.0 (11/09/09)
Closed:   04/03/2010 @ $0.0 ( n/a) in 145 days)


Comments (6)

Add Comment

Arrow_up
Arrow_down
wwj_edhardy   N/A     1 point   commented 673 days ago reply

ed hardy,
cheap ed hardy,
ed hardy clothing,
ed hardy outlet,
ed hardy jeans,
ed hardy bags,
ed hardy swimwear,
ed hardy shirts,
ed hardy tee,
ed hardy caps,
ed hardy purse,
ed hardy board shorts,
ed hardy shoes,
ed hardy for men,
ed hardy for women,
ed hardy jeans for women.

Arrow_up
Arrow_down
ozipek   N/A     1 point   commented 416 days ago reply

biber hapı | Maurers | zayıflama | Lw6090 | altın çilek | Ozon Yağı | Red Pepper | fx15 | radian | Tengda Zayıflama Hapı | Tengda Kullanımı | Tengda Kullanıcı Yorumları | Tengda Sipariş | Tengda Hakkında | Tengda İçindekiler | Tengda Etkileri | Tengda Yan Etkileri | Maurers | Maurers Kullanımı | Maurers Kullanıcı Yorumları | Maurers Sipariş | Maurers Hakkında | Maurers Zayıflama Hapı | Maurers İçindekiler | Maurers Etkileri | Maurers Yan Etkileri |

Arrow_up
Arrow_down
kevin21   N/A     1 point   commented 402 days ago reply

headphones


beats by dr dre

Arrow_up
Arrow_down
xiaofeifei   N/A     1 point   commented 372 days ago reply

Monster Beats is the world's earliest headset brand, quality is very high, and the sound quality is quite good, when you have Monster Headphones, you can hear the most beautiful music. Now many web site have
Monster Beats outlet, more and more young people like its fashion, cool dazzle,
Monster Headphones outletMonster Headphones outlet is so cheap, but also can make you feel good value for money.http://www.okbeats.net

Arrow_up
Arrow_down
wwee   N/A     1 point   commented 355 days ago reply

Harrison on Thursday because of competition in the collision of the Saints Drew Brees was fined $ 20,000, which is already coach online the third time this season because of the risk intercept Union fine. Three penalties totaling $ 100,000 fine, including the October 17 to Browns wide receiver Mohamed Massa Coy Knocked fined $ 75,000 concussion. “The number of penalty is becoming a problem,” Harrison said Thursday. “They punished me, two of which can not even be called the foul, I do not know what to say.” $ 75,000 of the tickets is out two weeks ago, when the NFL players on the head and neck for impact has taken a more hardline approach, and implementation of this policy has been retired to have the idea of Harrison. ed hardy clothes Harrison also because of the Sept. 19 race will be Titans quarterback Vince – Young knocked to the ground fined 5,000 U.S. dollars. The collision and the collision that Massa Coy’s not a penalty.

In Harrison collision occurred on Brisbane, the Union president Roger Goodell also on Tuesday the three-time all-star linebacker called New York the conversation. Harrison is expected to be fined, but the number of fines was very surprised, he insists he did not violate league policy. NFL Jerseys‘ hard-line policies in the style of sturdy and physically strong pride in the Steelers very unpopular. Coach Mike omlin and president of Art Rooney II think Harrison Massa clash for the league within the rules. Steelers coach outlet online, star coach outlet, safety of health policy for the Union, also expressed dissatisfaction, even though his own career, has at least 7 had brain concussion.

Arrow_up
Arrow_down
canadagoosel   N/A     1 point   commented 286 days ago reply

1Doubt sick

A man who often doubt himself getting sick guarded said to the doctor:headphones on sale "I must have had the cure of liver disease.loui vuitton wallet "The doctor declared:discount beats by dre" nonsense!! How can you know suffer from the disease?” That kind of disease does not make you feel unwell. "callaway golf irons

"Heavens!"boots shoes shop. The man gasping, "my situation is what it is!" discount north face jackets


2、Reason of diseasediscount louis vuitton purses

The doctor stare fierce in the eye and ask the patient: " where do you feel uncomfortable?" the north face outlet"I feel uncomfortable everywhere."designer handbags for less"How long do that last?" sunglasses wholesale

"From the start when I see you.” The patient said.loui vuitton outlet stores

3
reebok simply tonethe young intern doctor asked to the attending doctor: "why do you always forget to ask the costs of the patient’s usual eating dinner?" Doctor smiled and answered him: "this is extremely important, according to the patient's diet, classical Reebok running shoes on saleI can judge how much medical treatment I could charge to him."monster beats dre


4 The professor asked a studentleather boots the orally of some medicine:reebok zigtech" What is the amount every time.”monster beats on sale

The student answered: "5 grams."reebok couponA minute later, he found himself was wrong, it should be 5 mg, so he hurried and stand up and say:

"Professor, could you allow me to correct?" callaway golf on sale

Professor looked at the table, and then said: discount north face jackets

"No. Because of an overdose of drugs, patients have unfortunately died 30 seconds ago!" callaway preowned golf

5The world syndrome loui vuitton purse

The doctor asked the patient's history, the patient said: ugg boots sale"When I was very young, I had English disease, 5 years later I was caught with Spanish flu; not long ago, an eye doctor felt out my eyes with Egypt inflammation."reebok careers

"So, you had the world syndrome.fur boots" The doctor said with the diagnosis. classical Reebok running shoes on sale


Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.36% 531
2 18.14 +36.28% 286
3 17.66 +23.07% 83
4 13.47 +13.37% 69
5 12.13 +132.16% 102


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
ImmunoCellular Therapeutics Ltd. (IMUC)
   SocialPicks Sentiment:    N/A

   This Quarter's Sentiment:
All:
100.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
AMRN Positive +86.01% 11/29/10
IBB Positive +39.69% 11/22/10
EXAS Positive +35.19% 10/21/10
BIOD Positive -83.37% 10/17/10
LCI N/A Positive -21.73% 10/06/10

View All >
   
Mike Havrilla previously rated IMUC
Positive n/a Immune-Based Treatments for Brain Cancer Post Impressive Early-Stage Results
04/03/2010
1
Positive n/a ProActive HavRx Stock Indexes: Highlights and Opportunities
11/07/2009
1
Positive n/a ImmunoCellular (OTC: IMUC.OB): Impressive P1 Survival Data for Brain Cancer Vaccine
10/27/2009
1
Positive n/a ImmunoCellular (OTC: IMUC.OB): Delivering on Key Milestones
09/30/2009
1
Positive n/a BioMed News Bytes: Arena (NASDAQ: ARNA), ImmunoCellular (OTC: IMUC.OB), YM Bio (AMEX: YMI)
09/17/2009
1
Positive n/a Quantum Immunologics: Rodman Conference Recap
09/15/2009
1
Positive n/a ImmunoCellular (OTC: IMUC.OB): After Roche Deal, What’s Next?
09/14/2009
1
Positive n/a ImmunoCellular (OTC: IMUC): Roche Pact Validates Pipeline Potential
09/09/2009
1
Positive n/a Small-Cap Stocks Battling Brain Cancer
09/06/2009
1
Positive n/a ImmunoCellular: Leading Developer for a New Paradigm in Cancer Treatment
09/01/2009
1
Positive n/a ImmunoCellular (IMUC.OB): Taking Aim at the Root of Cancer
08/26/2009
1
Positive n/a Mentor Capital (MNTR.PK): A Stealth Cancer Immunotherapy Play
08/26/2009
1
Positive n/a New Index of Cancer Diagnostic and Therapeutic Stocks
04/12/2009
1
Positive +0.00% BioMedReports.com Most Popular Links
04/09/2009
1
Positive +0.00% ImmunoCellular Therapeutics: Targeting Cancer Stem Cells
04/01/2009
1





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch